Abivax S.A.
ABVX | NASDAQ
$105.04
-$1.95 (-1.82%)
At close: Sep 18, 2026, 4:00 PM ET
$106.16
+$1.12 (+1.07%)
Pre-market:
Sep 21, 2026, 8:54 AM ET
Market Data
Market Cap $7.71B
Enterprise Value $6.1B
Beta -0.25
Average Volume 1.71M
Shares Outstanding (Diluted) 69.53M
Shares Change YoY 43.98%
Institutional Ownership 71.97%
Exchange NASDAQ
ISIN US00370M1036
Price Performance
Price Change 1M -12.9%
Price Change 3M 3.3%
Price Change 6M -9.0%
Price Change YTD -21.5%
Price Change 1Y 26.1%
Price Change 3Y 1165.5%
Price Change 5Y 1165.5%
1M CAGR (ann.) -19.2%
1Y CAGR (ann.) 29.7%
5Y CAGR (ann.) N/A
All-Time CAGR 138.8%
Valuation
PE Ratio -25.11
Forward PE N/A
PEG Ratio 0.31
Forward PEG 3.80
PS Ratio N/A
Forward PS 66.50
PB Ratio 14.43
P/FCF Ratio -65.02
P/Adj. FCF Ratio -68.07
P/OCF Ratio -39.76
EV/Sales N/A
EV/EBIT -20.20
EV/EBITDA -20.27
EV/FCF -58.26
Earnings Yield -4.0%
FCF Yield -1.6%
Adj. FCF Yield -1.5%
Financial Health
Net Cash €472.13M
Total Debt €45.89M
Cash & Short-Term Investments €530.16M
Total Assets €652.05M
Current Ratio 8.75
Quick Ratio 8.75
Debt / Equity Ratio 0.10
Debt / EBITDA -0.15
Debt / FCF -0.44
OCF / Debt -2.28
Interest Coverage -8.79
Altman Z-Score 25.77
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -4.5%
Returns
Return on Assets -57.5%
Return on Equity -165.2%
Return on Invested Capital -45.5%
Return on Capital Employed -48.1%
Return on Tangible Assets -60.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.0%
Revenue CAGR 5Y 39.2%
Revenue CAGR 10Y -37.8%
EPS CAGR 3Y -16.6%
EPS CAGR 5Y -21.4%
EPS CAGR 10Y -12.0%
FCF CAGR 3Y -34.1%
FCF CAGR 5Y -45.2%
FCF CAGR 10Y -27.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y 77.2%
Revenue Growth Next 3Y N/A
Earnings Date Sep 20, 2026
EPS Estimate (next Q) -$1.13
EPS Growth Est (next Q) 14.2%
Revenue Est (next Q) $917.32K
Revenue Growth Est (next Q) -39.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $153
Price Target Upside 45.7%
Cash Flow
Operating Cash Flow €-104.62M
Free Cash Flow €-104.63M
Adj. Free Cash Flow €-99.95M
FCF Per Share -$2.33
OCF Per Share -$2.33
OCF/S Ratio 0.0%
Income Statement
Revenue €0
Gross Profit €0
Operating Income €-246.06M
EBITDA €-300.7M
Net Income €-336.1M
EPS (Diluted) -$3.69
Revenue / Employee N/A
Profit / Employee $-4.2M
Employees 80
Add to Watchlist
Select watchlists to add or remove ABVX